Lansoprazole Sulfone,
lansoprazole sulphone,
Lansoprazole Sulfone,
131926-99-3,
UNII-A62FAW18P1,
A62FAW18P1,
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole,
AG 1813,
1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfonyl)-,
1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-,
Lansoprazole sultone,
AG-1813,
SCHEMBL106666,
CTK6B3681,
DTXSID80157268,
BCP17469,
ZINC21981235,
AKOS015914410,
API0000623,
AC-30440,
RT-013553,
FT-0670723,
Lansoprazole EP Impurity B (Lansoprazole Sulfone),
A1-04640,
J-006088,
I14-41521,
1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-,
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfonyl)-1H-1,3-benzodiazole,
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole,
2-[[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDYL]-METHYL]SULPHONYL]-BENZIMIDAZOLE,
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfonyl]-1H-benzimidazole,
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzimidazole,
Lansoprazole Related Compound A, United States Pharmacopeia (USP) Reference Standard,
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl} sulfonyl)-1h-1,3-benzimidazole,
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole (Lansoprazole Sulphone),
lansoprazole sulphone,
CS-O-10332,
CID10385385,
lansoprazole sulfone, 98% - 10mg 10mg,
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzoimidazole,